open access publication

Article, 2024

Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding

Science Advances, ISSN 2375-2548, Volume 10, 22, 10.1126/sciadv.adl5576

Contributors

Chen Q. [1] Cai P. Chang T.H.W. [1] Burgener E. [2] [3] Kratochvil M.J. [1] Gupta A. [1] Hargill A. [1] Secor P.R. [4] Nielsen J.E. 0000-0001-9274-5533 [5] [6] Barron A.E. 0000-0002-0735-6873 [6] Milla C. 0000-0001-5515-3053 [3] Heilshorn S.C. Spakowitz A.J. (Corresponding author) Bollyky P.L. (Corresponding author) [1]

Affiliations

  1. [1] Stanford University Medical School
  2. [NORA names: United States; America, North; OECD];
  3. [2] Keck School of Medicine
  4. [NORA names: United States; America, North; OECD];
  5. [3] Stanford University
  6. [NORA names: United States; America, North; OECD];
  7. [4] University of Montana
  8. [NORA names: United States; America, North; OECD];
  9. [5] Roskilde University
  10. [NORA names: RUC Roskilde University; University; Denmark; Europe, EU; Nordic; OECD];

Abstract

Despite great progress in the field, chronic Pseudomonas aeruginosa (Pa) infections remain a major cause of mortality in patients with cystic fibrosis (pwCF), necessitating treatment with antibiotics. Pf is a filamentous bacteriophage produced by Pa and acts as a structural element in Pa biofilms. Pf presence has been associated with antibiotic resistance and poor outcomes in pwCF, although the underlying mechanisms are unclear. We have investigated how Pf and sputum biopolymers impede antibiotic diffusion using pwCF sputum and fluorescent recovery after photobleaching. We demonstrate that tobramycin interacts with Pf and sputum polymers through electrostatic interactions. We also developed a set of mathematical models to analyze the complex observations. Our analysis suggests that Pf in sputum reduces the diffusion of charged antibiotics due to a greater binding constant associated with organized liquid crystalline structures formed between Pf and sputum polymers. This study provides insights into antibiotic tolerance mechanisms in chronic Pa infections and may offer potential strategies for novel therapeutic approaches.

Funders

  • Cisco University Research Program Fund
  • Stanford University
  • Cystic Fibrosis Foundation Chen21F0
  • Stanford Maternal and Child Health Research Institute
  • National Science Foundation
  • truchard Foundation
  • Cystic Fibrosis Foundation
  • Silicon Valley Community Foundation
  • nordisk Foundation

Data Provider: Elsevier